Company / EPS (Diluted)
Astrana Health, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$1.29
FY2025
5-year range
$0.39 / $1.52
FY2021-FY2025
Trend
+30.3%
vs FY2024
Sector context
#71 of 159
Health Care
What the data says
At $1.29, Astrana Health, Inc.'s eps (diluted) ranks #71 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $-0.37 in FY2016 to $1.52 in FY2023.
Based on SEC 10-K filings.
1.29 in FY2025 with a 5-year CAGR of +34.8%.
Declined from $1.52 to $1.29 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +8.5%
- 5-Year CAGR
- +34.8%
- 10-Year CAGR
- -
Sector benchmark
#71 of 159 in Health CareTop 45% of 159This company $1.29 Sector average $1.56
▼
-17.1% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 30.3% year-over-year.
- Ranks #71 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.29 | +30.3% |
| FY2024 | $0.99 | -34.9% |
| FY2023 | $1.52 | +50.5% |
| FY2022 | $1.01 | +159.0% |
| FY2021 | $0.39 | +34.5% |
| FY2020 | $0.29 | -67.8% |
| FY2019 | $0.90 | +0.0% |
| FY2018 | $0.90 | +119.5% |
| FY2017 | $0.41 | +210.8% |
| FY2016 | -$0.37 | +73.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026